Intravenous isosorbide dinitrate in acute left ventricular failure--a dose--response study

Area of Science:

• Cardiology
• Pharmacology

Background:

• Severe acute left ventricular failure presents significant hemodynamic challenges.
• Intravenous vasodilators are crucial in managing acute heart failure.

Purpose of the Study:

• To assess the hemodynamic effects of intravenous isosorbide dinitrate in severe acute left ventricular failure.
• To determine optimal infusion rates for isosorbide dinitrate therapy.

Main Methods:

• Patients with severe acute left ventricular failure received intravenous isosorbide dinitrate infusions.
• Infusion rates were incrementally increased from 50 to 800 micrograms min-1.
• Hemodynamic parameters including pulmonary arterial diastolic pressure and cardiac index were monitored.

Main Results:

• Pulmonary arterial diastolic pressure significantly decreased from 29 to 23 mmHg at 200 micrograms min-1 (P < 0.001).
• Cardiac index and heart rate remained stable throughout the study.
• No adverse side effects were observed even at higher infusion rates.

Conclusions:

• Intravenous isosorbide dinitrate is an effective and safe treatment for acute severe left ventricular failure.
• An infusion rate of approximately 200 micrograms min-1 provides optimal hemodynamic benefits.
• This dosage allows for significant reduction in pulmonary arterial diastolic pressure without compromising cardiac output or heart rate.